Epitope-loaded nanoemulsion delivery system with ability of extending antigen release elicits potent Th1 response for intranasal vaccine against Helicobacter pylori

Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice

(2018) Rui Tada et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Immune response effects of diverse vaccine antigen attachment ways based on the self-made nanoemulsion adjuvant in systemic MRSA infection

(2018) Liu-yang Yang et al.   RSC Advances

Intranasal immunization with immunodominant epitope peptides derived from HpaA conjugated with CpG adjuvant protected mice against Helicobacter pylori infection

(2018) Wu-Chen Yang et al.   VACCINE

Nasal nanovaccines

(2017) B. Bernocchi et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Topical immunization using a nanoemulsion containing bacterial membrane antigens

(2017) Ibai Tamayo et al.   JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY

An immunogenic personal neoantigen vaccine for patients with melanoma

(2017) Patrick A. Ott et al.   NATURE

Vaccine adjuvant MF59 promotes the intranodal differentiation of antigen-loaded and activated monocyte-derived dendritic cells

(2017) Rossella Cioncada et al.   PLoS One

IL-22-induced antimicrobial peptides are key determinants of mucosal vaccine-induced protection against H. pylori in mice

(2016) M Moyat et al.   Mucosal Immunology

Nasal and pulmonary vaccine delivery using particulate carriers

(2015) Yimei Jia et al.   Expert Opinion on Drug Delivery

Current Status and Prospects for a Helicobacter pylori Vaccine

(2015) Thomas G. Blanchard et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Intranasal immunization with an epitope-based vaccine results in earlier protection, but not better protective efficacy, against Helicobacter pylori compared to subcutaneous immunization

(2015) Haibo Li et al.   IMMUNOLOGIC RESEARCH

Induction of systemic and mucosal immunity against methicillin-resistant Staphylococcus aureus infection by a novel nanoemulsion adjuvant vaccine

(2015) Hongwu Sun et al.   International Journal of Nanomedicine

Natural IgM Switches the Function of Lipopolysaccharide-Activated Murine Bone Marrow-Derived Dendritic Cells to a Regulatory Dendritic Cell That Suppresses Innate Inflammation

(2015) P. I. Lobo et al.   JOURNAL OF IMMUNOLOGY

Vaccine Adjuvant MF59 Promotes Retention of Unprocessed Antigen in Lymph Node Macrophage Compartments and Follicular Dendritic Cells

(2015) Rocco Cantisani et al.   JOURNAL OF IMMUNOLOGY

The effects of nanoparticle drug loading on the pharmacokinetics of anticancer agents

(2015) Jennifer S Petschauer et al.   Nanomedicine

Regulatory T cells may participate in Helicobacter pylori persistence in gastric MALT lymphoma: lessons from an animal model

(2015) Amandine Marine Laur et al.   Oncotarget

Immunodominant epitope-specific Th1 but not Th17 responses mediate protection against Helicobacter pylori infection following UreB vaccination of BALB/c mice

(2015) Bin Li et al.   Scientific Reports

Distinct Pathways of Humoral and Cellular Immunity Induced with the Mucosal Administration of a Nanoemulsion Adjuvant

(2014) A. U. Bielinska et al.   JOURNAL OF IMMUNOLOGY

Potent Immune Responses in Rhesus Macaques Induced by Nonviral Delivery of a Self-amplifying RNA Vaccine Expressing HIV Type 1 Envelope With a Cationic Nanoemulsion

(2014) W. M. Bogers et al.   JOURNAL OF INFECTIOUS DISEASES

Formulation and Characterization of Nanoemulsion Intranasal Adjuvants: Effects of Surfactant Composition on Mucoadhesion and Immunogenicity

(2013) Pamela T. Wong et al.   MOLECULAR PHARMACEUTICS

Advances in the study of HLA-restricted epitope vaccines

(2013) Lingxiao Zhao et al.   Human Vaccines & Immunotherapeutics

The history of MF59®adjuvant: a phoenix that arose from the ashes

(2012) Derek T O’Hagan et al.   Expert Review of Vaccines

A Dominant CD4+ T-Cell Response to Helicobacter pylori Reduces Risk for Gastric Disease in Humans

(2012) Li Chen et al.   GASTROENTEROLOGY

Development and characterization of a novel nanoemulsion drug-delivery system for potential application in oral delivery of protein drugs

(2012) Hongwu Sun et al.   International Journal of Nanomedicine

Low-energy formation of edible nanoemulsions: Factors influencing droplet size produced by emulsion phase inversion

(2012) Felix Ostertag et al.   JOURNAL OF COLLOID AND INTERFACE SCIENCE

Surface-Engineered Gold Nanorods: Promising DNA Vaccine Adjuvant for HIV-1 Treatment

(2012) Ligeng Xu et al.   NANO LETTERS

A Novel Inactivated Intranasal Respiratory Syncytial Virus Vaccine Promotes Viral Clearance without Th2 Associated Vaccine-Enhanced Disease

(2011) Dennis M. Lindell et al.   PLoS One

Use of defined TLR ligands as adjuvants within human vaccines

(2010) Malcolm S. Duthie et al.   IMMUNOLOGICAL REVIEWS

A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pylori

(2010) Carl-Fredrik Flach et al.   VACCINE

Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists

(2009) Jörg Vollmer et al.   ADVANCED DRUG DELIVERY REVIEWS

TLR9 as a key receptor for the recognition of DNA☆

(2008) Y KUMAGAI et al.   ADVANCED DRUG DELIVERY REVIEWS

Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues

(2008) Samuel K. Lai et al.   ADVANCED DRUG DELIVERY REVIEWS

Enhanced mucosal and systemic immune response with squalane oil-containing multiple emulsions upon intranasal and oral administration in mice

(2008) Aliasgar Shahiwala et al.   JOURNAL OF DRUG TARGETING

Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization

(2008) Ying-Jie Lu et al.   PLoS Pathogens

Effects of a Th1- versus a Th2-biased immune response in protection against Helicobacter pylori challenge in mice

(2007) Jennifer M. Taylor et al.   MICROBIAL PATHOGENESIS